Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: o Data of Individuals tested with Positive RT- PCR/ viral nucleic acid test for COVID-19 will be accessed o Patients Presenting with mild / No symptoms (Isolation ward participants data will be accessed) o Patients Presenting with moderate/ severe symptoms of COVID â?? 19 (ICU participants data will be accessed)
Exclusion criteria
Exclusion criteria: Following Records of investigations will not be accessed: o Data of Individuals with Liver disease, Rheumatoid arthritis, Renal disease & cardiac disease will not be accessed. o Reports presenting with any other bacterial infections will not be accessed o Reports of Pregnant women and age below o Data of Patients presenting with dengue, malaria infections will not be acquired.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To understand the biochemical alterations and prognosis of the COVID â?? 19 pandemic infectionTimepoint: 6 - 7 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Elevated LDH values were associated with 6- fold increased odds of severe COVID-19 infection. Hyper ferritinemia directly contributes to immune-suppressive and pro-inflammatory effects, and contributing to the cytokine storm and increased severity of the disease. Higher levels of hs-CRP can be a predictive marker in determining inflammatory response in COVID â?? 19.Timepoint: 6 - 7 months | — |
Countries
India
Contacts
Sri Ramachandra institute of Higher Education & Research, SRIHER(DU)